Increased Levels of TNF-α, IL-6, and IL-10 are Associated with The Degree of Liver Fibrosis in Chronic Hepatitis B Patients with NUC Therapy

• Main Authors: Ummi Maimunah, Ummi, Ulfa Kholili, -, Rheza Rahmadika Putra, -, Dio Brimantyo, -, Hendy Wirantara, -
• Format: Article PeerReviewed
• Language: English; Indonesian; English; English; Indonesian
• Published: The Prodia Education and Research Institute
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/133348/1/1%20artikel.pdf; https://repository.unair.ac.id/133348/2/1%20karil.pdf; https://repository.unair.ac.id/133348/3/1%20turnitin.pdf; https://repository.unair.ac.id/133348/4/1%20korespondensi.pdf; https://repository.unair.ac.id/133348/5/1%20etik.pdf; https://repository.unair.ac.id/133348/; https://inabj.org/index.php/ibj/article/view/2848; https://doi.org/10.18585/inabj.v16i1.2848
• Institution: Universitas Airlangga

Abstract BACKGROUND: Liver fibrosis in chronic hepatitis B (CHB) involves the host immune responses mainly T-lymphocyte regulatory cells and cytokines production. Tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 have been reported to play a crucial role in the development of liver fib...